Skip Navigation

You may want to learn about the results of past clinical trials and what they could mean for you.

The Be The Match Patient Support Center works with researchers at the Center for International Blood and Marrow Transplant Research (CIBMTR) to share easy-to-read summaries of some clinical trials.

Talk with your doctor about what the study results might mean for you.

2015 Research News

Allogeneic transplant may be a good treatment option for patients 40 years or older with non-Hodgkin lymphoma (PDF) This summary discusses how well transplants work (outcomes) in patients who are 40 years older who have non-Hodgkin lymphoma.

Guidelines on cancer screening for transplant recipients (PDF) This summary explains the common new cancers patients get after transplant, and how researchers developed guidelines for cancer screening specifically for transplant recipients.

Guidelines for transplant and multiple myeloma (PDF) Learn about the guidelines researchers developed to help doctors decide if an autologous transplant should be recommended for a patient with multiple myeloma.

Fertility preservation options before transplant (PDF) This summary discusses why some doctors don’t talk to patients about fertility preservation before transplant, and provides questions to ask your doctor about fertility if you’re considering transplant.

Patients with lymphoma have similar survival after transplant whether the unrelated donor is match, mismatched or cord blood (PDF) This summary explains what researchers found when comparing outcomes for patients with lymphoma who had a transplant using a matched unrelated donor, mismatched unrelated donor or a donated umbilical cord blood unit.

More patients who have a transplant from an unrelated donor survive than in the past (PDF) Learn what researchers say are the reasons survival rates have increased for patients who had a transplant from an unrelated donor increased in all of the age groups they studied.

More teens and young adults with ALL survive after blood or marrow transplant than in the past (PDF) This summary explains how 5-year survival rates after transplant have improved for patients 15 to 40 years old with acute lymphoblastic leukemia.

Patients with relapsed/refractory Follicular Lymphoma may benefit from a reduced-intensity allogeneic transplant (PDF) This summary discusses how an autologous (auto) transplant or a reduced-intensity allogeneic (allo) transplant can help patients with follicular lymphoma.

Individualized care plans for transplant recipients: an example of patient-centered research (PDF) Learn about the importance of patient-centered research and explore an example of one.

National survey of transplant center resources, staff, and structure (PDF) This summary discusses survey findings that can help transplant centers plan their resources, staff, and structure to be able to take care of future patients.

Bone marrow donors have more side effects at hospitals that do fewer bone marrow collections (PDF) This summary discusses the possible side effects for donors based on donor race or ethnicity, average household income, and how many times per year a hospital collects bone marrow or peripheral blood stem cell (PBSC).

Transplant can help some children with hypodiploid acute lymphoblastic leukemia (PDF) This summary discusses how transplant can be a good option for many children with hypodiploid acute lymphoblastic leukemia (ALL).

A new way to measure acute graft-versus-host disease can help doctors predict transplant outcomes (PDF) This summary discusses how the Refined Acute GVHD Risk Score can help doctors decide how best to treat a patient’s acute GVHD.

New blood test can predict the severity of acute graft-versus-host disease (PDF) Learn the importance of a doctor knowing a patient’s GVHD risk score, so they can recommend treatment that is best for that patient.

Patients with myeloma or lymphoma can have excellent outcomes after an outpatient autologous transplant (PDF) This summary explains what researchers found when comparing transplant outcomes between patients who got transplant as an outpatient and patients who got transplant as an inpatient.

The research news summaries are provided by the Consumer Advocacy Committee of CIBMTR® (Center for International Blood and Marrow Transplant Research®). The National Marrow Donor Program®/Be The Match® conducts research through our research program, CIBMTR, in collaboration with Medical College of Wisconsin.